Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy.
Kidney Int
; 99(6): 1275-1279, 2021 06.
Article
en En
| MEDLINE
| ID: mdl-33931226
ABSTRACT
In this issue of Kidney International, the initial experience regarding the immunogenicity of prior coronavirus disease 2019 (COVID-19) infection and the response to the COVID-19 vaccines among patients on maintenance dialysis and kidney transplant recipients is summarized. Preliminary data suggest that there is durability of immune response after COVID-19 infection. Although immune response to the first dose of vaccine is less in infection-naïve patients than healthy individuals in both groups, after the second vaccine dose a significant portion of patients receiving maintenance dialysis develop robust antibody titers, whereas kidney transplant recipients show a less-strong immune response.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Diálisis Renal
/
Trasplante de Riñón
/
Vacunas contra la COVID-19
/
COVID-19
Límite:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Año:
2021
Tipo del documento:
Article